Skip to main content
Niloufer Khan, MD, Oncology, Duarte, CA, City of Hope Comprehensive Cancer Center

NilouferKhanMDMSCE

Oncology • Duarte, CA

Cutaneous Lymphoma, Hematologic Oncology

Assistant Professor of Medicine

Request Appointment

Overview of Dr. Khan

Dr. Niloufer Khan is an oncologist in Duarte, CA and is affiliated with City of Hope Comprehensive Cancer Center. She received her medical degree from Case Western Reserve University School of Medicine and has been in practice 7 years. She is one of 198 doctors at City of Hope Comprehensive Cancer Center who specialize in Oncology. She has more than 30 publications and over 500 citings.

Education & Training

  • Weill Cornell Graduate School of Medical Sciences
    Weill Cornell Graduate School of Medical SciencesMS, Clinical Epidemiology and Health Services Research, 2018 - 2020
  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2016 - 2019
  • University of Chicago
    University of ChicagoResidency, Internal Medicine/Pediatrics, 2012 - 2016
  • Case Western Reserve University School of Medicine
    Case Western Reserve University School of MedicineClass of 2012, M.D., Alpha Omega Alpha, Honors and Distinction in Research
  • Case Western Reserve University
    Case Western Reserve UniversityB.A., Major: Biology/ International Studies; Minor: Spanish and Chemistry, 2004 - 2008

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2022 - Present
  • CA State Medical License
    CA State Medical License 2023 - 2025
  • NY State Medical License
    NY State Medical License 2016 - 2023
  • NJ State Medical License
    NJ State Medical License 2021 - 2023
  • IL State Medical License
    IL State Medical License 2015 - 2016
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Chief Hematology Fellow Memorial Sloan Kettering Cancer Center, 2018-2019
  • Young Investigator Award Conquer Cancer Foundation/American Society of Clinical Oncology, 2017
  • Alpha Omega Alpha, Honor Society Case Western Reserve University SOM, 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Current Selection Patterns, Toxicities and Outcomes of Pre-Transplant Salvage Treatment Regimens in Patients with Relapsed/Refractory Hodgkin Lymphoma: Results of a Mu...
    Niloufer Khan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Erythrocytosis associated with exogenous testosterone replacement.
    Khan N, Rossi-Foulkes, R, ACP Illinois Northern Residents’ and Medical Students’ Day, Chicago, IL, 1/21/2015
  • Efficacy of single-agent decitabine in relapsed and primary refractory AML.
    Hantel A, Khan N, Larson RA, Godley LA, Thirman MJ, Artz A, Odenike O, Liu H, Churpek JE, King D, Rich E, Choi KJ, Knoebel RW, Stock W, American Society of Hematology, Orlando, FL, 1/6/2015
  • Join now to see all

Lectures

  • A Phase II, Multicenter Study of High Dose Chemotherapy with Autologous Stem Cell Transplant Followed By Maintenance Therapy with Romidepsin for T-Cell Lymphoma 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

  • Lymphoma Research Foundation Funds 29 Grants Investigating Lymphoma and Chronic Lymphocytic Leukemia, Introduces Expanded Research Program and Health Equity Initiative
    Lymphoma Research Foundation Funds 29 Grants Investigating Lymphoma and Chronic Lymphocytic Leukemia, Introduces Expanded Research Program and Health Equity InitiativeMarch 31st, 2021

Professional Memberships

Hospital Affiliations

Dr. Niloufer Khan, Dr. Niloufer Khan, MD, Dr. N Khan